Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)

Market Cap	4.79B +119.7%
Revenue (ttm)	225.16M +1.9%
Net Income	-215.74M
EPS	-1.49
Shares Out	142.05M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.14 (0.45%)
Ex-Dividend Date	n/a

Volume	6,546,080
Open	30.95
Previous Close	33.73
Day's Range	30.95 - 36.36
52-Week Range	15.22 - 37.11
Beta	0.53
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHE:300878

Zhejiang Wecome Pharmaceutical Company Limited engages in the research and development, production, and sale of modern traditional Chinese and western medicine in China. The company offers products in various forms, including hard capsules, tablets, granules, soft capsules, pills, and other dosage forms. It also operates the retail of pharmaceutical commercial products. The company was formerly known as Zhejiang Weikang Pharmaceutical Co., Ltd. Zhejiang Wecome Pharmaceutical Company Limited was founded in 2000 and is based in Lishui, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 650
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300878

Financial Performance

In 2025, SHE:300878's revenue was 225.27 million, a decrease of -35.86% compared to the previous year's 351.20 million. Losses were -227.34 million, 54.2% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 23, 2026

Data Sources Report a data error